These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 27008643

  • 1. C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum.
    Al-Ghaithi B, Chanchlani R, Riedl M, Thorner P, Licht C.
    Pediatr Nephrol; 2016 Nov; 31(11):2079-86. PubMed ID: 27008643
    [Abstract] [Full Text] [Related]

  • 2. C3 glomerulopathy in a patient with a history of post-infectious glomerulonephritis.
    Nnadi N, Hendricks AR, Torrealba J, Drake KA, Gattineni J.
    Pediatr Nephrol; 2024 Mar; 39(3):745-748. PubMed ID: 37874356
    [Abstract] [Full Text] [Related]

  • 3. C3 glomerulonephritis with a severe crescentic phenotype.
    Ravindran A, Fervenza FC, Smith RJH, Sethi S.
    Pediatr Nephrol; 2017 Sep; 32(9):1625-1633. PubMed ID: 28593446
    [Abstract] [Full Text] [Related]

  • 4. The C3 conundrum.
    Lean M, Chacko B.
    Intern Med J; 2023 Jun; 53(6):1065-1069. PubMed ID: 37278101
    [Abstract] [Full Text] [Related]

  • 5. C3 glomerulopathy and current dilemmas.
    Ito N, Ohashi R, Nagata M.
    Clin Exp Nephrol; 2017 Aug; 21(4):541-551. PubMed ID: 27878657
    [Abstract] [Full Text] [Related]

  • 6. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J, Berenberg-Goßler L, Wu K, Beringer O, Kropp F, Müller D, Thumfart J.
    Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151
    [Abstract] [Full Text] [Related]

  • 7. Clinical and pathological features of 52 patients with glomerulonephritis with dominant C3.
    Wei J, Huang Y, Yuan S, Chen X, Fu X, Li Z, Li Y, Sun L, Liu H, Zhu X.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan 28; 49(1):75-83. PubMed ID: 38615169
    [Abstract] [Full Text] [Related]

  • 8. C3 nephritic factor associated with C3 glomerulopathy in children.
    Nicolas C, Vuiblet V, Baudouin V, Macher MA, Vrillon I, Biebuyck-Gouge N, Dehennault M, Gié S, Morin D, Nivet H, Nobili F, Ulinski T, Ranchin B, Marinozzi MC, Ngo S, Frémeaux-Bacchi V, Pietrement C.
    Pediatr Nephrol; 2014 Jan 28; 29(1):85-94. PubMed ID: 24068526
    [Abstract] [Full Text] [Related]

  • 9. Characterization of C3 in C3 glomerulopathy.
    Sethi S, Vrana JA, Fervenza FC, Theis JD, Sethi A, Kurtin PJ, Zhang Y, Smith RJH.
    Nephrol Dial Transplant; 2017 Mar 01; 32(3):459-465. PubMed ID: 27507892
    [Abstract] [Full Text] [Related]

  • 10. Validation of a Histologic Scoring Index for C3 Glomerulopathy.
    Caravaca-Fontán F, Trujillo H, Alonso M, Díaz-Encarnación M, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez-Mendiola N, Cruz S, Fernández-Juárez G, Rodríguez E, de la Cerda F, Pérez de José A, López I, Fernández L, Pérez Gómez V, Ávila A, Bravo L, Lumbreras J, Allende N, Sanchez de la Nieta MD, Olea T, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, de Lorenzo A, Draibe J, González F, Shabaka A, Illescas ML, Calvo C, Oviedo V, Da Silva I, Goicoechea de Jorge E, Caravaca F, Praga M, C3G Study Group of the Spanish Group for the Study of Glomerular Diseases (GLOSEN).
    Am J Kidney Dis; 2021 May 01; 77(5):684-695.e1. PubMed ID: 33359150
    [Abstract] [Full Text] [Related]

  • 11. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.
    Ravindran A, Fervenza FC, Smith RJH, Sethi S.
    Kidney Int; 2018 Jul 01; 94(1):178-186. PubMed ID: 29729982
    [Abstract] [Full Text] [Related]

  • 12. Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children.
    Ueda C, Horinouchi T, Inoki Y, Ichikawa Y, Tanaka Y, Kitakado H, Kondo A, Sakakibara N, Nagano C, Yamamura T, Fujimura J, Kamiyoshi N, Ishimori S, Ninchoji T, Kaito H, Shima Y, Iijima K, Nozu K, Yoshikawa N.
    Pediatr Nephrol; 2024 Sep 01; 39(9):2679-2689. PubMed ID: 38662234
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Kidney Transplantation in C3 Glomerulopathy: A Case Series.
    Regunathan-Shenk R, Avasare RS, Ahn W, Canetta PA, Cohen DJ, Appel GB, Bomback AS.
    Am J Kidney Dis; 2019 Mar 01; 73(3):316-323. PubMed ID: 30413277
    [Abstract] [Full Text] [Related]

  • 20. Clinico-Pathogenic Similarities and Differences between Infection-Related Glomerulonephritis and C3 Glomerulopathy.
    Wada Y, Kamata M, Miyasaka R, Abe T, Kawamura S, Takeuchi K, Aoyama T, Oda T, Takeuchi Y.
    Int J Mol Sci; 2023 May 08; 24(9):. PubMed ID: 37176142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.